Series D

Evolve BioSystems revolves to series D

12th February 2021

Jordan Williams

UC Davis's probiotics spinout secured an undisclosed amount as Bow Capital backed the first close of a series D round with a $55m target.

Daily deal net: February 9, 2021

9th February 2021

Thierry Heles

Today's deal net contains news from Nexthink, Metalenz, Grapheal, CellulaRevolution and Astrata.

Soci cements $80m series D

26th January 2021

Callum Cyrus

Retail brand management business Soci has assembled $115m to date from investors including Stanford University's Daper Fund.

J-Pharma jacks series D up to $21m

19th January 2021

Liwen-Edison Fu

Fidelity provided a $4.8m second tranche after a first close featuring vehicles for Kyushu University and Osaka University.

Investors hook up Hinge Health with $300m

7th January 2021

Thierry Heles

IP Group portfolio company Hinge Health has pushed its valuation to $3bn following a $300m series D round co-led by Coatue Management and Tiger Global.

Gojo finds series D mojo

18th December 2020

Callum Cyrus

Tokyo University of Science helped extend Gojo & Company's series D round to $68.6m, lifting the microfinancing provider's overall funding to around $142m.

Investors endow Endomag with $20m

1st December 2020

Callum Cyrus

Existing backers including Draper Esprit and Sussex Place Ventures have reinvested to bring Endomag’s overall funding to above $43m.

Recursion takes $239m funding excursion

10th September 2020

Robert Lavine

University of Utah's drug discovery technology producer has raised series D funding to increase its post-money valuation to some $1.2bn.

Other News

Climeworks stretches out for $110m close

2nd September 2020

Callum Cyrus

ETH Zurich-founded carbon capture system producer Climeworks has added $35m to its latest round to fund further business growth.

StreetLight Data cruises into $15m series D

7th August 2020

Callum Cyrus

Osage University Partners has returned to bring the big urban transit data analytics company's funding total to more than $40m.

Ginger gives zest to series D

7th August 2020

Thierry Heles

Cigna and Kaiser Permanente have participated in a $50m series D round for Ginger, bringing the MIT spinout's total funding to more than $120m.

PMV padlocks $70m series D

5th August 2020

Callum Cyrus

Osage University Partners-backed PMV has pushed its funding total to $236m as it further commercialises Princeton research stretching back to 1979.

J-Pharma takes in $16.3m

30th July 2020

Callum Cyrus

Osaka University Venture Capital was among the investors in a series D round for Kyorin University-founded cancer treatment developer J-Pharma.

Scalable Capital mounts $58m series D campaign

23rd July 2020

Thierry Heles

Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.

Editor's Picks

Big deal: Oxford PV begins capturing series D

18th March 2019

Thierry Heles

Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.

test reg